Summary - AI in Drug Discovery and Application in Türkiye – Market Research

by ✨ OPUS4i 1mo ago

Introduction

Artificial intelligence (AI) is revolutionizing drug discovery by dramatically reducing development times and costs. Globally, pharma companies are partnering with AI startups to accelerate R&D. Türkiye is embracing this trend: local startups are exploring AI for drug development, and international AI-driven biotech firms are extending their reach into the Turkish market. This report surveys AI startups and companies in Türkiye focused on medical drug discovery and the guidance of final application processes (e.g. clinical trials and regulatory approval) using AI. We outline available AI tools, their features and use cases, underlying technology stacks, pricing models (where available), key team members, contacts, and relevant regulatory considerations in Türkiye.

Domestic AI Startups in Türkiye (Drug Discovery & Development)

  • Company websites and profiles

International AI Companies Operating in Türkiye

  • Many leading AI-driven drug discovery companies are global
  • Sources: Press and company materials

AI Tools, Features, and Use Cases

  • Available AI Tools
  • Final application guidance (clinical decision support)
  • Features & Use Cases
  • Drug Candidate Generation
  • Target Identification & Validation
  • Drug Repurposing
  • Clinical Trial Optimization
  • Regulatory Document Automation

Technology Stack

The underlying tech often involves a blend of machine learning techniques and domain-specific data

Pricing Models

  • Pricing and Business Models

Key Executives and Teams

Each company’s leadership blends AI expertise and biomedical experience

Official Websites and Contacts

  • Domestic
  • International

It’s worth noting that no international AI-drug companies have dedicated Turkish offices yet.

Regulatory Aspects in Türkiye (AI & Drug Discovery)

Navigating the regulatory landscape is critical for AI-enabled drug discovery, especially in the “final application” stages (clinical trials and marketing authorization). In Türkiye, the regulatory framework is evolving to accommodate AI/

  • AI-Specific Regulations: As of early 2025
  • Clinical Trials: TİTCK
  • Marketing Authorization
  • Data Protection
  • Turkish patent law & EPC
  • Government Initiatives